• Publications
  • Influence
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with a high prevalence. The etiology of this heterogeneous condition remains obscure, and its phenotype expressionExpand
  • 893
  • 65
  • Open Access
Ultrasound assessment of the polycystic ovary: international consensus definitions.
The polycystic ovary syndrome (PCOS) is a heterogeneous condition, the pathophysiology of which appears to be both multifactorial and polygenic. The definition of the syndrome has been much debated.Expand
  • 826
  • 46
  • Open Access
The physiology and clinical utility of anti-Mullerian hormone in women.
BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been applied to a wide array of clinical applications, mainly based on its ability to reflect the number of antral andExpand
  • 462
  • 29
Non-invasive amino acid turnover predicts human embryo developmental capacity.
BACKGROUND IVF is limited by low success rates and a confounding high multiple birth rate contributing to prematurity, increased neonatal mortality and child handicap. These problems could beExpand
  • 339
  • 23
  • Open Access
Quality of life and psychological well being in polycystic ovary syndrome.
BACKGROUND Polycystic ovary syndrome (PCOS) is associated with poor quality of life (QoL) and high levels of depression. Existing research is confounded by small sample sizes and inconsistent use ofExpand
  • 243
  • 23
  • Open Access
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
The criteria for the diagnosis of the polycystic ovary syndrome (PCOS) have still not been agreed universally. A population of 1741 women with PCOS were studied, all of whom had polycystic ovariesExpand
  • 683
  • 21
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
BACKGROUND Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogaenemia and insulin resistance. Hyperinsulinaemia is associated with an increase in cardiovascular risk and theExpand
  • 222
  • 21
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
objective Polycystic ovary syndrome (PCOS) is more prevalent in South Asian women residing in the UK than in Caucasians. Insulin resistance (IR) is central to the pathogenesis of PCOS, while type 2Expand
  • 258
  • 16
A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
The outcome of in-vitro fertilization and embryo transfer (IVF-ET) was compared in 76 patients with polycystic ovaries (PCO) diagnosed on pre-treatment ultrasound scan, and 76 control patients whoExpand
  • 223
  • 15
The use of metformin for women with PCOS undergoing IVF treatment.
BACKGROUND Metformin appears to improve reproductive function in some women with polycystic ovary syndrome (PCOS). We wished to explore the effect of metformin in women with PCOS undergoing IVF. Expand
  • 176
  • 15
  • Open Access